Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older

BACKGROUND: Elderly patients are generally underrepresented in oncology clinical trials; therefore, real-world data are needed to inform clinical management of elderly patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2−) metastatic breast cancer (mBC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Brufsky, Adam, Liu, Xianchen, Li, Benjamin, McRoy, Lynn, Chen, Connie, Layman, Rachel M., Rugo, Hope S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569486/
https://www.ncbi.nlm.nih.gov/pubmed/37841423
http://dx.doi.org/10.3389/fonc.2023.1237751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569486/
https://www.ncbi.nlm.nih.gov/pubmed/37841423
http://dx.doi.org/10.3389/fonc.2023.1237751

Ejemplares similares